Meeting News
Meeting News
Melissa BadamoAcute Myeloid Leukemia | November 3, 2023
RNA sequencing showed decreased gene expression levels of the NF-κB target genes IL1β and IER3 after emavusertib treatment.
Read More
Leah SherwoodLatest Issue | October 11, 2023
The meeting had more than 2,500 registrants attending in person or online.
Joseph Mikhael, MDMeeting News | October 10, 2023
Researchers conducted interviews to gather the perspectives of both clinicians and nurses.
Nitin Jain, MDMeeting News | October 4, 2023
Nitin Jain, MD, joins Chadi Nabhan, MD, MBA, FACP, Host of The HemOnc Pulse, to discuss unmet needs in CLL.
Cecilia BrownMeeting News | September 29, 2023
Researchers conducted a cross-sectional survey of patients with multiple myeloma to address the question.
Jorge Cortes, MDVideo Insights | September 29, 2023
The award was created in honor of Michael J. Keating, MD, a founding member and past president of SOHO.
Joshua Richter, MDMyeloma | September 28, 2023
Dr. Richter discusses the data he presented during the 20th IMS Annual Meeting Exposition.
Cecilia BrownMeeting News | September 28, 2023
Researchers evaluated 1,704 patients with triple-class exposure, including 1,072 who had four-plus previous lines of therapy.
Loretta Nastoupil, MDMeeting News | September 25, 2023
Dr. Nastoupil spoke about how the meeting can help clinicians learn how apply knowledge from the latest research.
Karun Neupane, MDVideo Insights | September 22, 2023
Karun Neupane, MD, discusses why the meeting was a valuable experience for him as a first-time attendee.
Leah LawrenceMeeting News | September 19, 2023
Researchers presented updated data from the phase I XPORT-MF-034 trial at the Eleventh SOHO Annual Meeting.
Chadi Nabhan, MD, MBA, FACPMeeting News | September 14, 2023
Dr. de Lima discusses progress and remaining challenges with allogeneic CAR-T and other cellular therapy products.
Cecilia BrownMyelodysplastic Syndromes | September 14, 2023
The proof-of-concept study showed that noninvasive hemoglobin measurement is “feasible,” but there were several ...
Cecilia BrownMeeting News | September 14, 2023
One aim is to evaluate the efficacy of oral decitabine/cedazuridine and magrolimab in intermediate to HR MDS.
Swaminathan Iyer, MDVideo Insights | September 14, 2023
Swaminathan Iyer, MD, joins Chadi Nabhan, MD, MBA, FACP, to discuss advances in T-cell lymphoma.
Alessandra Ferrajoli, MDMeeting News | September 14, 2023
Alessandra Ferrajoli, MD, discusses her presentation on the topic during the Eleventh Annual Meeting of SOHO.
Chadi Nabhan, MD, MBA, FACPMyelodysplastic Syndromes | September 14, 2023
Joseph Khoury, MD; Sanam Loghavi, MD; and Chadi Nabhan, MD, MBA, FACP, discuss the MDS classification systems.
Mary Ann Anderson, MBBS, PhDMeeting News | September 13, 2023
Dr. Anderson spoke about her plenary session on the topic at the Eleventh Annual Meeting of SOHO.
Chadi Nabhan, MD, MBA, FACPMeeting News | September 13, 2023
Dr. Garcia-Manero discusses key data from the phase III COMMANDS trial.
Cecilia BrownChronic Lymphocytic Leukemia | September 11, 2023
All patients included in the study required treatment and had not previously received psychiatric treatment.
Editorial Board